{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:28:13Z","timestamp":1792420093838,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.jhep.2014.09.032","type":"journal-article","created":{"date-parts":[[2014,10,17]],"date-time":"2014-10-17T01:03:27Z","timestamp":1413507807000},"page":"332-339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt"],"prefix":"10.1016","volume":"62","author":[{"given":"Marie-Luise","family":"Berres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Asmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"G\u00f6rtzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger M.","family":"Strunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Fimmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian P.","family":"Strassburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Trautwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Sauerbruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann Elard","family":"Wasmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonel","family":"Trebicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2014.09.032_b0005","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.09.032_b0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(00)80422-5","article-title":"Complications of cirrhosis. Portal hypertension","volume":"32","author":"Bosch","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.09.032_b0015","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrgastro.2010.168","article-title":"Functional role of chemokines in liver disease models","volume":"7","author":"Sahin","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2014.09.032_b0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0030-1255351","article-title":"Chemokines in liver inflammation and fibrosis","volume":"30","author":"Wasmuth","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2014.09.032_b0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/cei.12032","article-title":"CXCR3 axis in patients with primary biliary cirrhosis: a possible novel mechanism of the effect of ursodeoxycholic acid","volume":"172","author":"Manousou","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhep.2014.09.032_b0030","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/hep.25545","article-title":"Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice","volume":"55","author":"Sahin","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.09.032_b0035","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jhep.2011.07.017","article-title":"Targeted impairment of innate antiviral responses in the liver of chronic hepatitis C patients","volume":"56","author":"Jouan","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.09.032_b0040","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.3748\/wjg.14.7149","article-title":"Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection","volume":"14","author":"Larrubia","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2014.09.032_b0045","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/hep.22500","article-title":"Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C","volume":"48","author":"Zeremski","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.09.032_b0050","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/hep.21986","article-title":"CXCL10 regulates liver innate immune response against ischemia and reperfusion injury","volume":"47","author":"Zhai","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.09.032_b0055","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaut.2005.08.009","article-title":"Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives","volume":"25","author":"Chuang","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jhep.2014.09.032_b0060","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1111\/j.1572-0241.2002.07054.x","article-title":"Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease","volume":"97","author":"Apolinario","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2014.09.032_b0065","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/hep.24098","article-title":"Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection","volume":"53","author":"Berres","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.09.032_b0070","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s10096-010-0981-4","article-title":"Soluble inflammatory markers as predictors of liver histological changes in patients with chronic hepatitis C virus infection","volume":"29","author":"Moura","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jhep.2014.09.032_b0075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/j.gastro.2009.03.053","article-title":"Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans","volume":"137","author":"Wasmuth","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.09.032_b0080","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/infdis\/jir424","article-title":"CXCL9 and CXCL10 chemokines as predictors of liver fibrosis in a cohort of primarily African-American injection drug users with chronic hepatitis C","volume":"204","author":"Zeremski","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2014.09.032_b0085","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1086\/646614","article-title":"Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection","volume":"200","author":"Zeremski","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2014.09.032_b0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cyto.2011.10.020","article-title":"High plasma CXCL10 levels are associated with HCV-genotype 1, and higher insulin resistance, fibrosis, and HIV viral load in HIV\/HCV coinfected patients","volume":"57","author":"Berenguer","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.jhep.2014.09.032_b0095","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1478-3231.2011.02504.x","article-title":"Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases","volume":"31","author":"Tacke","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2014.09.032_b0100","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00024382-200206000-00013","article-title":"CXC chemokine expression after stimulation with interferon-gamma in primary rat hepatocytes in culture","volume":"17","author":"Ren","year":"2002","journal-title":"Shock"},{"key":"10.1016\/j.jhep.2014.09.032_b0105","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.26069","article-title":"Proapoptotic effects of the chemokine, CXCL 10 are mediated by the noncognate receptor TLR4 in hepatocytes","volume":"57","author":"Sahin","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.09.032_b0110","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.1128\/JVI.06872-11","article-title":"CD44 participates in IP-10 induction in cells in which hepatitis C virus RNA is replicating, through an interaction with Toll-like receptor 2 and hyaluronan","volume":"86","author":"Abe","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.09.032_b0115","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jaut.2010.09.003","article-title":"CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation","volume":"35","author":"Hintermann","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jhep.2014.09.032_b0120","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1189\/jlb.0303093","article-title":"Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation","volume":"74","author":"Harvey","year":"2003","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jhep.2014.09.032_b0125","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/hep.20167","article-title":"Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation","volume":"39","author":"Helbig","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.09.032_b0130","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/lt.22451","article-title":"Serum cytokine profiles associated with early allograft dysfunction in patients undergoing liver transplantation","volume":"18","author":"Friedman","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2014.09.032_b0135","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1177\/135965350801300815","article-title":"IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection","volume":"13","author":"Reiberger","year":"2008","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhep.2014.09.032_b0140","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1245\/ASO.2003.10.002","article-title":"Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery","volume":"10","author":"Chao","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jhep.2014.09.032_b0145","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/vim.2011.0035","article-title":"CXCR3 expression elevated on peripheral CD8(+) lymphocytes from HIV\/HCV coinfected individuals","volume":"24","author":"Kimball","year":"2011","journal-title":"Viral Immunol"},{"key":"10.1016\/j.jhep.2014.09.032_b0150","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2014.09.032_b0155","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1080\/003655202320378284","article-title":"Hemodynamic effects of propranolol and nitrates in cirrhotics with transjugular intrahepatic portosystemic stent-shunt","volume":"37","author":"Brensing","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2014.09.032_b0160","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/MEG.0b013e32834a75dc","article-title":"Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt","volume":"23","author":"Trebicka","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2014.09.032_b0165","doi-asserted-by":"crossref","first-page":"e83341","DOI":"10.1371\/journal.pone.0083341","article-title":"Soluble TNF-alpha-receptors I are prognostic markers in TIPS-treated patients with cirrhosis and portal hypertension","volume":"8","author":"Trebicka","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2014.09.032_b0170","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.4049\/jimmunol.1003750","article-title":"CXCR3 deficiency exacerbates liver disease and abrogates tolerance in a mouse model of immune-mediated hepatitis","volume":"186","author":"Erhardt","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2014.09.032_b0175","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2249.2001.01391.x","article-title":"Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes","volume":"123","author":"Nishioji","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhep.2014.09.032_b0180","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nrgastro.2012.96","article-title":"Recent advances in our understanding of hepatorenal syndrome","volume":"9","author":"Wong","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2014.09.032_b0185","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882781400734X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882781400734X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T02:08:48Z","timestamp":1650420528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882781400734X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S016882781400734X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2014.09.032","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2014.09.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}